Springleaf Therapeutics
SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on convergent science and is designed to enable and differentiate...Homepage: http://www.springleaftx.com
Total money raised: $19M
02215
8 St. Mary's Street
Suite 601
Boston
USA MA
Suite 601
Boston
USA MA
Phone: 1-617-358-4927
Updated on Sep 19, 2012
Springleaf Therapeutics at CrunchBase
Pieter Muntendam President and CEOSpringleaf Therapeutics at CrunchBase
Past
July, 2011
Springleaf Therapeutics raised $4M in a Series B round from Excel Venture Management
SpringLeaf Therapeutics Announces Second Close of Series B Financing 
springleaftx.com
May, 2011
Springleaf Therapeutics raised $15M in a Series B round from SR One, Flybridge Capital Partners, and North Bridge Venture Partners
SpringLeaf Therapeutics raises $15M Series B round 
masshightech.com